Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

73 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Targeted therapy with kinase inhibitors in aggressive endocrine tumors.
Marotta V, Franzese MD, Del Prete M, Chiofalo MG, Ramundo V, Esposito R, Marciello F, Pezzullo L, Carratù A, Vitale M, Colao A, Faggiano A. Marotta V, et al. Expert Opin Pharmacother. 2013 Jun;14(9):1187-203. doi: 10.1517/14656566.2013.796931. Expert Opin Pharmacother. 2013. PMID: 23675883 Review.
The evolving field of kinase inhibitors in thyroid cancer.
Marotta V, Sciammarella C, Vitale M, Colao A, Faggiano A. Marotta V, et al. Crit Rev Oncol Hematol. 2015 Jan;93(1):60-73. doi: 10.1016/j.critrevonc.2014.08.007. Epub 2014 Sep 16. Crit Rev Oncol Hematol. 2015. PMID: 25240824 Review.
Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Gambardella C, Grasso M, Antonino A, Annunziata A, Macchia PE, Pivonello R, Santini L, Botti G, Losito S, Pezzullo L, Colao A, Faggiano A. Marotta V, et al. J Clin Endocrinol Metab. 2017 Feb 1;102(2):661-671. doi: 10.1210/jc.2016-2555. J Clin Endocrinol Metab. 2017. PMID: 27849428
Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.
Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A. Marotta V, et al. Endocrine. 2017 Sep;57(3):539-543. doi: 10.1007/s12020-016-1200-6. Epub 2016 Dec 16. Endocrine. 2017. PMID: 27981515 No abstract available.
Erratum to: Preliminary data of VEGF-A and VEGFR-2 polymorphisms as predictive factors of radiological response and clinical outcome in iodine-refractory differentiated thyroid cancer treated with sorafenib.
Marotta V, Sciammarella C, Capasso M, Testori A, Pivonello C, Chiofalo MG, Pivonello R, Pezzullo L, Botti G, Colao A, Faggiano A. Marotta V, et al. Endocrine. 2017 Sep;57(3):544. doi: 10.1007/s12020-017-1269-6. Endocrine. 2017. PMID: 28243971 No abstract available.
Hashimoto's thyroiditis predicts outcome in intrathyroidal papillary thyroid cancer.
Marotta V, Sciammarella C, Chiofalo MG, Gambardella C, Bellevicine C, Grasso M, Conzo G, Docimo G, Botti G, Losito S, Troncone G, De Palma M, Giacomelli L, Pezzullo L, Colao A, Faggiano A. Marotta V, et al. Endocr Relat Cancer. 2017 Sep;24(9):485-493. doi: 10.1530/ERC-17-0085. Epub 2017 Jul 10. Endocr Relat Cancer. 2017. PMID: 28696209
Human exposure to bisphenol AF and diethylhexylphthalate increases susceptibility to develop differentiated thyroid cancer in patients with thyroid nodules.
Marotta V, Russo G, Gambardella C, Grasso M, La Sala D, Chiofalo MG, D'Anna R, Puzziello A, Docimo G, Masone S, Barbato F, Colao A, Faggiano A, Grumetto L. Marotta V, et al. Chemosphere. 2019 Mar;218:885-894. doi: 10.1016/j.chemosphere.2018.11.084. Epub 2018 Nov 17. Chemosphere. 2019. PMID: 30609493
73 results